Cargando…
Optimisation of Folate-Mediated Liposomal Encapsulated Arsenic Trioxide for Treating HPV-Positive Cervical Cancer Cells In Vitro
High-risk human papilloma virus (HPV) infection is directly associated with cervical cancer development. Arsenic trioxide (ATO), despite inducing apoptosis in HPV-infected cervical cancer cells in vitro, has been compromised by toxicity and poor pharmacokinetics in clinical trials. Therefore, to imp...
Autores principales: | Akhtar, Anam, Ghali, Lucy, Wang, Scarlet Xiaoyan, Bell, Celia, Li, Dong, Wen, Xuesong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539325/ https://www.ncbi.nlm.nih.gov/pubmed/31052347 http://dx.doi.org/10.3390/ijms20092156 |
Ejemplares similares
-
Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study
por: Akhtar, Anam, et al.
Publicado: (2018) -
Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancers
por: Akhtar, Anam, et al.
Publicado: (2017) -
Therapeutic Potential of Delivering Arsenic Trioxide into HPV-Infected Cervical Cancer Cells Using Liposomal Nanotechnology
por: Wang, Xiaoyan, et al.
Publicado: (2016) -
Arsenic trioxide encapsulated liposomes prepared via copper acetate gradient loading method and its antitumor efficiency
por: Wang, Shaoning, et al.
Publicado: (2020) -
Effect of arsenic trioxide on cervical cancer and its mechanisms
por: Zhang, Liping, et al.
Publicado: (2020)